FindTrial
Sign In

Triptan overuse in migraine in primary care, a proactive approach

Triptan overuse in migraine in primary care, a proactive approach - LIMIT-study Leiden Improvement of MIgraine Therapy in general practice

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON30289
Enrollment
600
Registered
2007-07-16
Start date
2007-03-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine

Interventions

Proactive stepped approach based on the Dutch GP Guideline versus usual care. Step 1: a letter to invite patients for consultation. Step 2: a visit to the GP, who can give information about headache

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. registered in Electronic Patient Register of the GP 2. prescriptions for triptans, dosed 24 doses or more per year (or 6 or more daily doses in the last 6 months)

Exclusion criteria

Exclusion criteria: younger than 18 years old cognitive impairment psychiatric illness end-stage of a malignant disease non-Dutch speaking

Design outcomes

Primary

MeasureTime frame
Reduction of score on the HIT-6 questionnaire (measuring headache impact) at six months after the start of the intervention.—

Secondary

MeasureTime frame
HIT-6 questionnaire at 3 and 12 months follow up *migraine frequency (diary over 1 month as used in Dutch General Practice, to be filled in at baseline and follow up moments) *quality of life (questionnaires: visual analogue scale and societal EQ-5D) *triptan/analgesic use (information from prescriptions registered in EPR) *prophylactic medication (information from prescriptions registered in EPR)—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)